Makers Laboratories Ltd
BSE:506919
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
M
|
Makers Laboratories Ltd
BSE:506919
|
840.2m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
295.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
245.2B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.1B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Makers Laboratories Ltd
Glance View
Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 145 full-time employees. The firm is engaged in the manufacturing and marketing of pharmaceuticals. The Company’s segments include Pharmaceutical and Chemical Manufacturing. Its product portfolio covers a range of General Health Therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB (a-b Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). The firm also provides a range of diabetic and hypertensive drugs including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), Hypernorm range (Telmisartan). Its Inspira retail packs division includes anthelmintics, anti-allergic, anti-biotics, anti-diabetics, anti-diarrheal, anti-fungal, anti-hypertensives, anti-inflammatory, analgesic, antispasmodic. Its Experia bulk packs division includes Betamethasone 0.5 mg Tablets, Chloramphenicol Capsules 250 mg, and Chloroquine Phosphate 250 mg Tablets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Makers Laboratories Ltd is 0%, which is above its 3-year median of -0.8%.
Over the last 3 years, Makers Laboratories Ltd’s Net Margin has increased from -0.8% to 0%. During this period, it reached a low of -6% on Mar 31, 2024 and a high of 7.1% on Jun 30, 2025.
